Dafna Capital Management LLC Oric Pharmaceuticals, Inc. Transaction History

Dafna Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.63 - $12.93 $238,680 - $465,480	36,000 New	36,000 $254,000
Q4 2023 Feb 14, 2024	BUY	$5.41 - $9.43 $393,831 - $686,475	72,797 New	72,797 $669,000
Q1 2023 May 15, 2023	SELL	$4.26 - $6.75 $400,060 - $633,899	-93,911 Reduced 35.54%	170,326 $970,000
Q4 2022 Feb 14, 2023	SELL	$2.41 - $5.89 $359,786 - $879,312	-149,289 Reduced 36.1%	264,237 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $7,560 - $12,576	-2,400 Reduced 0.58%	413,526 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $1.12 Million - $2.94 Million	415,926 New	415,926 $1.86 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.